Nephrogenic systemic fibrosis Treatment in Hyderabad


Systemic nephrogenic fibrosis is a rare disease that occurs primarily in people with advanced kidney disease, with or without dialysis. Systemic nephrogenic fibrosis can resemble skin diseases such as scleroderma and scleromyxedema, with thickening and darkening developing over large areas of the skin.

Systemic nephrogenic fibrosis can also affect internal organs such as the heart, kidneys, and lungs and prevent the muscles and tendons in the joints from shortening (joint contracture). Nephrogenic systemic fibrosis Treatment in Hyderabad


ystemic nephrogenic fibrosis can begin days to months after exposure to a contrast agent containing gadolinium. Some signs and symptoms of nephrogenic systemic fibrosis may include:

The reasons

The exact cause of nephrogenic systemic fibrosis is not fully understood. Exposure to gadolinium-containing contrast agents during magnetic resonance imaging (MRI) has been identified as a trigger for the development of this disease. The Food and Drug Administration (FDA) recommends avoiding gadolinium-containing contrast agents in people with acute kidney failure or chronic kidney disease. Nephrogenic systemic fibrosis Treatment in Hyderabad

Other conditions that may lead to or promote disease with severe kidney disease and exposure to a gadolinium-containing contrast agent include the following:

Risk factors

The highest risk of nephrogenic systemic fibrosis after exposure to gadolinium is in those who:

Leave a Reply

Your email address will not be published. Required fields are marked *